Ceesay Abraham: insider trades.
Ceesay Abraham reported 17 non-derivative transactions on 7 SEC ownership filings in Q3 2026: 0 open-market purchases and 17 sales ($4.6M), across 1 company.
- Transactions
- 17
- Purchases (P)
- 0
- Sales (S)
- 17
- Companies
- 1
- Name as filed
- Ceesay Abraham
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | Director, Officer · Chief Executive Officer | 17 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-23 | Rapport Therapeutics, Inc. | S | 43 | $41.05 | 456,767 | Form 4 |
| 2026-09-23 | Rapport Therapeutics, Inc. | S | 1,952 | $39.05 | 457,025 | Form 4 |
| 2026-09-23 | Rapport Therapeutics, Inc. | S | 215 | $39.86 | 456,810 | Form 4 |
| 2026-09-08 | Rapport Therapeutics, Inc. | S | 7,141 | $45.56 | 460,046 | Form 4 |
| 2026-09-08 | Rapport Therapeutics, Inc. | S | 1,069 | $46.01 | 458,977 | Form 4 |
| 2026-08-25 | Rapport Therapeutics, Inc. | S | 18,921 | $49.57 | 467,187 | Form 4 |
| 2026-08-11 | Rapport Therapeutics, Inc. | S | 3,664 | $46.9 | 511,402 | Form 4 |
| 2026-08-11 | Rapport Therapeutics, Inc. | S | 19,500 | $48.04 | 491,902 | Form 4 |
| 2026-08-11 | Rapport Therapeutics, Inc. | S | 5,794 | $48.62 | 486,108 | Form 4 |
| 2026-08-10 | Rapport Therapeutics, Inc. | S | 14,171 | $45.97 | 523,436 | Form 4 |
| 2026-08-10 | Rapport Therapeutics, Inc. | S | 8,370 | $46.75 | 515,066 | Form 4 |
| 2026-07-27 | Rapport Therapeutics, Inc. | S | 2,203 | $42.11 | 537,614 | Form 4 |
| 2026-07-27 | Rapport Therapeutics, Inc. | S | 7 | $42.74 | 537,607 | Form 4 |
| 2026-07-14 | Rapport Therapeutics, Inc. | S | 2,729 | $40.57 | 539,817 | Form 4 |
| 2026-07-14 | Rapport Therapeutics, Inc. | S | 5,481 | $39.72 | 542,546 | Form 4 |
| 2026-06-29 | Rapport Therapeutics, Inc. | S | 876 | $40.34 | 548,027 | Form 4 |
| 2026-06-29 | Rapport Therapeutics, Inc. | S | 7,344 | $39.77 | 548,903 | Form 4 |
Questions
What stock did Ceesay Abraham buy or sell?
Ceesay Abraham reported 17 non-derivative transactions on 7 SEC ownership filings in Q3 2026: 0 open-market purchases and 17 sales ($4.6M), across 1 company.
Is Ceesay Abraham the same person as other filers with this name?
This page covers SEC CIK 1722140 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/ceesay-abraham-1722140.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.